Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19

Viral infections and antiphospholipid antibodies

Uthman, I. W., & Gharavi, A. E. (2002) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2002.28303 · Cited by 302

COVID-19 complicated by Hashimoto’s thyroiditis

Tee, L. Y., Harjanto, S., & Rosario, B. H. (2020) · Singapore Medical Journal · doi:10.11622/smedj.2020106 · Cited by 87

COVID-19 and the central nervous system

Alomari, S. O., Abou-Mrad, Z., & Bydon, A. (2020) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2020.106116 · Cited by 90

The Spectrum of Neuroimaging Findings on CT and MRI in Adults With COVID-19

Moonis, G., Filippi, C. G., Kirsch, C., Mohan, S., Stein, E. G., Hirsch, J. A., & Mahajan, A. K. (2020) · American Journal of Roentgenology · doi:10.2214/ajr.20.24839 · Cited by 88

SARS-COV-2-related immune-inflammatory thyroid disorders: facts and perspectives

Ruggeri, R. M., Campennì, A., Deandreis, D., Siracusa, M., Tozzoli, R., Ovčariček, P. P., & Giovanella, L. (2021) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1932467 · Cited by 90

Coronavirus Disease 2019 (COVID-19) as a Multi-Systemic Disease and its Impact in Low- and Middle-Income Countries (LMICs)

Temgoua, M. N., Endomba, F. T., Nkeck, J. R., Kenfack, G. U., Tochie, J. N., & Essouma, M. (2020) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00417-7 · Cited by 88

The hazard of (sub)therapeutic doses of anticoagulants in non‐critically ill patients with Covid‐19: The Padua province experience

Pesavento, R., Ceccato, D., Pasquetto, G., Monticelli, J., Leone, L., Frigo, A., Gorgi, D., Postal, A., Marchese, G. M., Cipriani, A., et al. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15022 · Cited by 86

Extrapulmonary Clinical Manifestations in COVID-19 Patients

Sarkesh, A., Sorkhabi, A. D., Sheykhsaran, E., Alinezhad, F., Mohammadzadeh, N., Hemmat, N., & Baghi, H. B. (2020) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.20-0986 · Cited by 89

COVID-19-Related Aortic Thrombosis: A Report of Four Cases

Gómez-Arbeláez, D., Sánchez, G. I., Garcia-Gutierrez, A., Yéboles, A. C., Ansuátegui, M., & González-Fajardo, J. A. (2020) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2020.05.031 · Cited by 85

Association between D-Dimer levels and mortality in patients with coronavirus disease 2019 (COVID-19): a systematic review and pooled analysis

Sakka, M., Connors, J. M., Hékimian, G., Martin‐Toutain, I., Crichi, B., Colmegna, I., Bonnefont‐Rousselot, D., Farge, D., & Frère, C. (2020) · JMV-Journal de Médecine Vasculaire · doi:10.1016/j.jdmv.2020.05.003 · Cited by 85

Entangling COVID-19 associated thrombosis into a secondary antiphospholipid antibody syndrome: Diagnostic and therapeutic perspectives (Review)

Cavalli, E., Bramanti, A., Ciurleo, R., Tchorbanov, A. I., Giordano, A., Fagone, P., Belizna, C. C., Bramanti, P., Shoenfeld, Y., & Nicoletti, F. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4659 · Cited by 85

Impact of COVID-19 on the Cardiovascular System: A Review of Available Reports

Soumya, R. S., Unni, T. G., & Raghu, K. G. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-07073-y · Cited by 92

Lung megakaryocytes display distinct transcriptional and phenotypic properties

Yeung, A. K., Villacorta-Martín, C., Hon, S. M., Rock, J. R., & Murphy, G. J. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020002843 · Cited by 91

Coagulopathy of COVID‐19 and antiphospholipid antibodies

Connell, N. T., Battinelli, E. M., & Connors, J. M. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14893 · Cited by 84

Coagulation Dysfunction

Fei, Y., Tang, N., Liu, H., & Cao, W. (2020) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2020-0324-sa · Cited by 88

Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management

Savla, S. R., Prabhavalkar, K. S., & Bhatt, L. K. (2021) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2021.1915129 · Cited by 88

SARS-CoV-2 and Stroke Characteristics

Shahjouei, S., Tsivgoulis, G. K., Farahmand, G., Koza, E., Mowla, A., Sadr, A. V., Kia, A., Far, A. V., Mondello, S., Cernigliaro, A., et al. (2021) · Stroke · doi:10.1161/strokeaha.120.032927 · Cited by 86

Association of COVID-19 vs Influenza With Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients

Re, V. L., Dutcher, S. K., Connolly, J. G., Pérez-Vilar, S., Carbonari, D. M., DeFor, T. A., Djibo, D. A., Harrington, L. B., Hou, L., Hennessy, S., et al. (2022) · JAMA · doi:10.1001/jama.2022.13072 · Cited by 88

Comment on “Characterization of acute acro-ischemic lesions in non-hospitalized patients: A case series of 132 patients during the COVID-19 outbreak”

Fernández‐Nieto, D., ­Jimenez‐Cauhe, J., Suárez‐Valle, A., Moreno‐Arrones, Ó. M., Saceda‐Corralo, D., Arana-Raja, A., & Ortega-Quijano, D. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2020.05.120 · Cited by 84

Erythropoietin as candidate for supportive treatment of severe COVID-19

Ehrenreich, H., Weißenborn, K., Begemann, M., Busch, M., Vieta, E., & Miskowiak, K. W. (2020) · Molecular Medicine · doi:10.1186/s10020-020-00186-y · Cited by 98

A critical review of the pathophysiology of thrombotic complications and clinical practice recommendations for thromboprophylaxis in pregnant patients with COVID‐19

D'Souza, R. D., Malhamé, I., Teshler, L., Acharya, G., Hunt, B. J., & McLintock, C. (2020) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.13962 · Cited by 84

Clinical Characteristics of Stroke with COVID-19: A Systematic Review and Meta-Analysis

Yamakawa, M., Kuno, T., Mikami, T., Takagi, H., & Gronseth, G. (2020) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2020.105288 · Cited by 83

Neurological Complications of COVID-19: Underlying Mechanisms and Management

Shehata, G. A., Lord, K. C., Grudzinski, M. C., Elsayed, M., Abdelnaby, R., & Elshabrawy, H. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084081 · Cited by 84

Hypoxia in COVID-19: Sign of Severity or Cause for Poor Outcomes

KASHANI, K. B. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.04.021 · Cited by 85

Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID‐19

Dobesh, P. P., & Trujillo, T. C. (2020) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2465 · Cited by 80

Blood Biomarkers for Detection of Brain Injury in COVID-19 Patients

DeKosky, S. T., Kochanek, P. M., Valadka, A. B., Clark, R. S. B., Chou, S., Au, A. K., Horvat, C. M., Jha, R. M., Mannix, R., Wisniewski, S. R., et al. (2020) · Journal of Neurotrauma · doi:10.1089/neu.2020.7332 · Cited by 87

Circulating Calprotectin as a Biomarker of COVID-19 Severity

Mähler, M., Meroni, P. L., Infantino, M. G., Buhler, K. A., & Fritzler, M. J. (2021) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1905526 · Cited by 82

Marked factor V activity elevation in severe COVID‐19 is associated with venous thromboembolism

Stefely, J. A., Christensen, B. B., Gogakos, T., Cone Sullivan, J. K., Montgomery, G. G., Barranco, J. P., & Van Cott, E. M. (2020) · American Journal of Hematology · doi:10.1002/ajh.25979 · Cited by 80

Small bowel ischemia and SARS-CoV-2 infection: an underdiagnosed distinct clinical entity

Ignat, M., Philouze, G., Aussenac-Belle, L., Faucher, V., Collange, O., Mutter, D., & Pessaux, P. (2020) · Surgery · doi:10.1016/j.surg.2020.04.035 · Cited by 79

Three novel prevention, diagnostic, and treatment options for COVID-19 urgently necessitating controlled randomized trials

Horowitz, R. I., & Freeman, P. R. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.109851 · Cited by 79

Anticardiolipin IgG Autoantibody Level Is an Independent Risk Factor for COVID‐19 Severity

Bertin, D., Brodovitch, A., Beziane, A., Hug, S., Bouamri, A., Mège, J., Heim, X., & Bardin, N. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41409 · Cited by 79

ISTH DIC subcommittee communication on anticoagulation in COVID‐19

Thachil, J. V., Juffermans, N. P., Ranucci, M., Connors, J. M., Warkentin, T. E., Ortel, T. L., Levi, M. M., Iba, T., & Levy, J. H. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15004 · Cited by 79

Prevalence of autoantibody responses in acute coronavirus disease 2019 (COVID-19)

Lerma, L. A., Chaudhary, A., Bryan, A. B., Morishima, C., Wener, M. H., & Fink, S. L. (2020) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2020.100073 · Cited by 80

Relationship between blood eosinophil levels and COVID-19 mortality

Yan, B., Yang, J., Xie, Y., & Tang, X. (2021) · World Allergy Organization Journal · doi:10.1016/j.waojou.2021.100521 · Cited by 79

Blood clots in COVID-19 patients: Simplifying the curious mystery

Biswas, S., Thakur, V., Kaur, P., Khan, A., Kulshrestha, S., & Kumar, P. (2021) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110371 · Cited by 74

Can COVID-19 pandemic boost the epidemic of neurodegenerative diseases?

Verkhratsky, A., Li, Q., Melino, S., Melino, G., & Shi, Y. (2020) · Biology Direct · doi:10.1186/s13062-020-00282-3 · Cited by 81

Hematopoietic responses to SARS-CoV-2 infection

Elahi, S. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04220-6 · Cited by 79

Gold Nanorod Assisted Enhanced Plasmonic Detection Scheme of COVID‐19 SARS‐CoV‐2 Spike Protein

Das, C. M., Guo, Y., Yang, G., Kang, L., Xu, G., Ho, H., & Yong, K. (2020) · Advanced Theory and Simulations · doi:10.1002/adts.202000185 · Cited by 76

Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection

Minniti, C. P., Zaidi, A. U., Nouraie, M. S., Manwani, D. G., Crouch, G. D., Crouch, A. S., Callaghan, M. U., Carpenter, S., Jacobs, C., Han, J., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003456 · Cited by 75

Heterogeneity in Regional Damage Detected by Neuroimaging and Neuropathological Studies in Older Adults With COVID-19: A Cognitive-Neuroscience Systematic Review to Inform the Long-Term Impact of the Virus on Neurocognitive Trajectories

Manca, R., Marco, M. D., Ince, P. G., & Venneri, A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.646908 · Cited by 77

Bilateral Adrenal Hemorrhage in Coronavirus Disease 2019 Patient: A Case Report

Frankel, M., Feldman, I., Levine, M. A., Frank, Y., Bogot, N., Benjaminov, O., Kurd, R., Breuer, G. S., & Munter, G. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa487 · Cited by 74

COVID-19 and Cerebrovascular Diseases: A Systematic Review and Perspectives for Stroke Management

Fraiman, P. H. A., Godeiro-Junior, C. D. O., Moro, E., Cavallieri, F., & Zedde, M. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.574694 · Cited by 78

Functional pathophysiology of SARS-CoV-2-induced acute lung injury and clinical implications

Habashi, N. M., Camporota, L., Gatto, L. A., & Nieman, G. F. (2021) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00742.2020 · Cited by 73

Perinatal Complications in Individuals in California With or Without SARS-CoV-2 Infection During Pregnancy

Ferrara, A. M., Hedderson, M. M., Zhu, Y., Avalos, L. A., Kuzniewicz, M. W., Myers, L. C., Ngo, A. L., Gunderson, E. P., Ritchie, J. L., Quesenberry, C. P., et al. (2022) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2022.0330 · Cited by 72

Red cell–bound antibodies and transfusion requirements in hospitalized patients with COVID-19

Berzuini, A., Bianco, C., Paccapelo, C., Bertolini, F., Gregato, G., Cattaneo, A., Erba, E., Bandera, A., Gori, A., Lamorte, G., et al. (2020) · Blood · doi:10.1182/blood.2020006695 · Cited by 73

Influenza Vaccination to Reduce Cardiovascular Morbidity and Mortality in Patients With COVID-19

Behrouzi, B., Campoverde, M. V. A., Liang, K., Talbot, H. K., Bogoch, I. I., McGeer, A., Fröbert, O., Loeb, M. B., Vardeny, O., Solomon, S. D., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.028 · Cited by 76

Presentation, Treatment Response and Short-Term Outcomes in Paediatric Multisystem Inflammatory Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS)

Felsenstein, S., Willis, E., Lythgoe, H., McCann, L. J., Cleary, A. G., Mahmood, K., Porter, D., Jones, J., McDonagh, J. E. R., Chieng, A., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103293 · Cited by 75

Induced dysregulation of ACE2 by SARS-CoV-2 plays a key role in COVID-19 severity

Mehrabadi, M. E., Hemmati, R., Tashakor, A., Homaei, A. A., Yousefzadeh, M., Hemati, K., & Hosseinkhani, S. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111363 · Cited by 75

COVID-19 Pathophysiology Predicts That Ischemic Stroke Occurrence Is an Expectation, Not an Exception—A Systematic Review

Wijeratne, T., Crewther, S. G., Sales, C., & Karimi, L. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.607221 · Cited by 75

Lipoprotein(a) and Its Potential Association with Thrombosis and Inflammation in COVID-19: a Testable Hypothesis

Moriarty, P. M., Gorby, L. K., Stroes, E. S. G., Kastelein, J. J. P., Davidson, M. H., & Tsimikas, S. (2020) · Current Atherosclerosis Reports · doi:10.1007/s11883-020-00867-3 · Cited by 72

Coronaviruses and the central nervous system

Morgello, S. (2020) · Journal of NeuroVirology · doi:10.1007/s13365-020-00868-7 · Cited by 70

COVID-19 Mechanisms in the Human Body—What We Know So Far

Kumar, A., Narayan, R. K., Prasoon, P., Kumari, C., Kaur, G., Kumar, S., Kulandhasamy, M., Sesham, K., Pareek, V., Faiq, M. A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.693938 · Cited by 76

Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship

D’Ardes, D., Boccatonda, A., Cocco, G., Fabiani, S., Rossi, I., Bucci, M., Guagnano, M. T., Schiavone, C., & Cipollone, F. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i11.1102 · Cited by 76

COVID-19 Associated Hypercoagulability: Manifestations, Mechanisms, and Management

Mazzeffi, M. A., Chow, J. H., & Tanaka, K. A. (2020) · Shock · doi:10.1097/shk.0000000000001660 · Cited by 71

Pathological post‐mortem findings in lungs infected with SARS‐CoV‐2

Damiani, S., Fiorentino, M., Palma, A. D., Foschini, M. P., Lazzarotto, T., Gabrielli, L., Viale, P., Attard, L., Riefolo, M., & D’Errico, A. (2020) · The Journal of Pathology · doi:10.1002/path.5549 · Cited by 71

COVID‐19: Neuroimaging Features of a Pandemic

Ladopoulos, T., Zand, R., Shahjouei, S., Chang, J. J., Motte, J., James, J. C., Katsanos, A. H., Kerro, A., Farahmand, G., Far, A. V., et al. (2021) · Journal of Neuroimaging · doi:10.1111/jon.12819 · Cited by 71

Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases

Furer, V., Rondaan, C., Agmon‐Levin, N., van Assen, S., Bijl, M., Kapetanovic, M. C., de Thurah, A. L., Müeller-Ladner, U., Paran, D., Schreiber, K. I., et al. (2021) · RMD Open · doi:10.1136/rmdopen-2021-001594 · Cited by 69

Retinal manifestations in patients with SARS-CoV-2 infection and pathogenetic implications: a systematic review

Sen, S., Kannan, N. B., Kumar, J., Rajan, R. P., Kumar, K., Baliga, G., Reddy, H., Upadhyay, A., & Ramasamy, K. (2021) · International Ophthalmology · doi:10.1007/s10792-021-01996-7 · Cited by 75

COVID-19 — Toward a comprehensive understanding of the disease

Kowalik, M. M., Trzonkowski, P., Łasińska-Kowara, M., Mital, A., Smiatacz, T., & Jaguszewski, M. J. (2020) · Cardiology Journal · doi:10.5603/cj.a2020.0065 · Cited by 71

Cell-Mediated Immune Responses to COVID-19 Infection

Guihot, A., Litvinova, E., Autran, B., Debré, P., & Vieillard, V. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01662 · Cited by 70

Association Between Pulmonary Embolism and COVID‐19 in Emergency Department Patients Undergoing Computed Tomography Pulmonary Angiogram: The PEPCOV International Retrospective Study

Freund, Y., Drogrey, M., Miró, Ò., Marra, A., Féral‐Pierssens, A., Penaloza, A., Hernández, B. A. L., Beaune, S., Gorlicki, J., Ayar, P. V., et al. (2020) · Academic Emergency Medicine · doi:10.1111/acem.14096 · Cited by 70

COVID ‐19, microthromboses, inflammation, and platelet activating factor

Demopoulos, C. A., Antonopoulou, S., & Theoharides, T. C. (2020) · BioFactors · doi:10.1002/biof.1696 · Cited by 71

Prevalence and outcome of silent hypoxemia in COVID-19

Busana, M., Gasperetti, A., Giosa, L., Forleo, G. B., Schiavone, M., Mitacchione, G., Bonino, C., Villa, P., Galli, M., Tondo, C., et al. (2021) · Minerva Anestesiologica · doi:10.23736/s0375-9393.21.15245-9 · Cited by 70

Early public adherence with and support for stay-at-home COVID-19 mitigation strategies despite adverse life impact: a transnational cross-sectional survey study in the United States and Australia

Czeisler, M. É., Howard, M. E., Robbins, R., Barger, L. K., Facer‐Childs, E. R., Rajaratnam, S. M. W., & Czeisler, C. A. (2021) · BMC Public Health · doi:10.1186/s12889-021-10410-x · Cited by 75

Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic

Dewanjee, S., Vallamkondu, J., Kalra, R. S., Puvvada, N., Kandimalla, R. J. L., & Reddy, P. H. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02450-6 · Cited by 73

COVID-19 and the brain

Hingorani, K. S., Bhadola, S., & Cervantes-Arslanian, A. M. (2022) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2022.04.004 · Cited by 70

Venous cerebral thrombosis in COVID-19 patient

Garaci, F. G., Giuliano, F. D., Picchi, E., Ros, V. D., & Floris, R. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.116871 · Cited by 70

Disentangling the Hypothesis of Host Dysosmia and SARS-CoV-2: The Bait Symptom That Hides Neglected Neurophysiological Routes

Briguglio, M., Bona, A. R., Porta, M., Dell’Osso, B. M., Pregliasco, F. E., & Banfi, G. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00671 · Cited by 70

Proper Management of People with Obesity during the COVID-19 Pandemic

Lim, S. K., Shin, S. M., Nam, G. E., Jung, C. H., & Koo, B. K. (2020) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes20056 · Cited by 72

Association between antithrombin and mortality in patients with COVID-19. A possible link with obesity

Gazzaruso, C., Paolozzi, E., Valenti, C., Brocchetta, M., Naldani, D., Grignani, C., Salvucci, F., Marino, F., Coppola, A., & Gallotti, P. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.07.040 · Cited by 69

Cerebral Venous Thrombosis in COVID-19: A New York Metropolitan Cohort Study

Al‐Mufti, F., Amuluru, K., Sahni, R., Bekelis, K., Karimi, R., Ogulnick, J. V., Cooper, J., Overby, P. J., Nuoman, R., Tiwari, A., et al. (2021) · American Journal of Neuroradiology · doi:10.3174/ajnr.a7134 · Cited by 69

SARS-CoV-2: Emerging Role in the Pathogenesis of Various Thyroid Diseases

Murugan, A. K., & Alzahrani, A. S. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s332705 · Cited by 72

Coagulation changes and thromboembolic risk in COVID-19 obstetric patients

Benhamou, D., Keïta, H., Ducloy-Bouthors, A. S., Benhamou, D., Bonnet, M., Bonnin, M., Bouthors, A. S., Bouvet, L., Castel, A., CHASSARD, D., et al. (2020) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2020.05.003 · Cited by 68

Silent COVID-19: what your skin can reveal

Guarneri, C., Rullo, E. V., Pavone, P., Berretta, M., Ceccarelli, M., Natale, A., & Nunnari, G. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30402-3 · Cited by 68

Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study

Vultaggio, A., Vivarelli, E., Virgili, G., Lucenteforte, E., Bartoloni, A., Nozzoli, C., Morettini, A., Berni, A., Malandrino, D., Rossi, O., et al. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.06.013 · Cited by 67

B-cell depletion with rituximab in the COVID-19 pandemic: where do we stand?

Mehta, P., Porter, J. C., Chambers, R. C., Isenberg, D. A., & Reddy, V. R. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30270-8 · Cited by 67

Autoimmunity as the comet tail of COVID-19 pandemic

Talotta, R., & Robertson, E. S. (2020) · World Journal of Clinical Cases · doi:10.12998/wjcc.v8.i17.3621 · Cited by 69

Novel paediatric presentation of COVID-19 with ARDS and cytokine storm syndrome without respiratory symptoms

Pain, C. E., Felsenstein, S., Cleary, G., Mayell, S. J., Conrad, K., Harave, S., Duong, P., Sinha, I. P., Porter, D., & Hedrich, C. M. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30137-5 · Cited by 66

Epithelial and Endothelial Expressions of ACE2: SARS-CoV-2 Entry Routes

Güney, C., & Akar, F. (2021) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/jpps31455 · Cited by 66

A randomized clinical trial evaluating the immunomodulatory effect of convalescent plasma on COVID-19-related cytokine storm

Pouladzadeh, M., Safdarian, M., Eshghi, P., Abolghasemi, H., bavani, A. G., Sheibani, B., Choghakabodi, P. M., Feghhi, A., Boroujerdnia, M. G., Forouzan, A., et al. (2021) · Internal and Emergency Medicine · doi:10.1007/s11739-021-02734-8 · Cited by 66

Catastrophic Antiphospholipid Syndrome

Bitsadze, V. O., Yakubova, F. E., Khizroeva, J. K., Владимировна, Л. А., Владимировна, С. П., Vorobеv, A. V., Tretyakova, M. V., Degtyareva, N. D., Grigoreva, K. N., Gashimova, N. R., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25010668 · Cited by 69

Relationship of chest CT score with clinical characteristics of 108 patients hospitalized with COVID-19 in Wuhan, China

Zhang, J., Meng, G., Li, W., Shi, B., Dong, H., Su, Z., Huang, Q., & Gao, P. (2020) · Respiratory Research · doi:10.1186/s12931-020-01440-x · Cited by 65

Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications

Mukherjee, P. K., Efferth, T., Das, B., Kar, A., Ghosh, S., Singha, S., Debnath, P., Sharma, N., Bhardwaj, P. K., & Haldar, P. K. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.153930 · Cited by 69

Heparin-induced thrombocytopenia is associated with a high risk of mortality in critical COVID-19 patients receiving heparin-involved treatmentPreprint

Liu, X., Zhang, X., Xiao, Y., Gao, T., Wang, G., Wang, Z., Zhang, Z., Hu, Y., Dong, Q., Zhao, S., et al. (2020) · medRxiv · doi:10.1101/2020.04.23.20076851 · Cited by 65

Pulmonary, Cerebral, and Renal Thromboembolic Disease in a Patient with COVID-19

Lushina, N., Kuo, J. S., & Shaikh, H. A. (2020) · Radiology · doi:10.1148/radiol.2020201623 · Cited by 64

Cold agglutinin autoimmune haemolytic anaemia associated with novel coronavirus (COVID‐19)

Zagorski, E., Pawar, T. A., Rahimian, S., & Forman, D. A. (2020) · British Journal of Haematology · doi:10.1111/bjh.16892 · Cited by 64

COVID-19 infection associated with autoimmune hemolytic anemia

Capes, A., Bailly, S., Hantson, P. E., Gérard, L., & Laterre, P. (2020) · Annals of Hematology · doi:10.1007/s00277-020-04137-9 · Cited by 64

Early Detection and Assessment of Covid-19

Hashmi, H. A. S., & Asif, H. M. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00311 · Cited by 73

Coagulopathy in COVID-19: Focus on vascular thrombotic events

Shi, W., Lv, J., & Lin, L. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.07.003 · Cited by 65

HMGB1: A Possible Crucial Therapeutic Target for COVID-19?

Street, M. E. (2020) · Hormone Research in Paediatrics · doi:10.1159/000508291 · Cited by 63

Lung and kidney perfusion deficits diagnosed by dual-energy computed tomography in patients with COVID-19-related systemic microangiopathy

İdilman, İ. S., Dizman, G. T., Düzgün, S. A., Irmak, İ., Karçaaltıncaba, M., İnkaya, A. Ç., Demirkazık, F., Durhan, G., Akpınar, M. G., Arıyürek, O. M., et al. (2020) · European Radiology · doi:10.1007/s00330-020-07155-3 · Cited by 62

Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System

Sparks, M. A., South, A. M., Badley, A. D., Baker-Smith, C. M., BATLLE, D. C., Bozkurt, B., Cattaneo, R., Crowley, S. D., Dell’Italia, L. J., Ford, A. L., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15948 · Cited by 62

COVID-19 and Its Implications for Thrombosis and Anticoagulation

Berkman, S. A., & Tapson, V. F. (2021) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0041-1722992 · Cited by 64

Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID‐19: A single‐center prospective longitudinal study

Juneja, G. K., Castelo, M., Yeh, C. H., Cerroni, S. E., Hansen, B. E., Chessum, J. E., Abraham, J., Cani, E., Dwivedi, D. J., Fraser, D. D., et al. (2021) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15327 · Cited by 63

Autoantibodies in COVID‐19 correlate with antiviral humoral responses and distinct immune signatures

Taeschler, P., Cervia, C., Zurbuchen, Y., Hasler, S., Pou, C., Tan, Z., Adamo, S., Raeber, M. E., Bächli, E., Rudiger, A., et al. (2022) · Allergy · doi:10.1111/all.15302 · Cited by 64

Pathophysiological involvement of host mitochondria in SARS-CoV-2 infection that causes COVID-19: a comprehensive evidential insight

Bhowal, C., Ghosh, S., Ghatak, D., & De, R. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04593-z · Cited by 63

Characteristics of Large-Vessel Occlusion Associated with COVID-19 and Ischemic Stroke

John, S., Kesav, P., Mifsud, V. A., Piechowski‐Jóźwiak, B., Dibu, J. R., Bayrlee, A., Elkambergy, H., Röser, F., Elhammady, M. S., Zahra, K., et al. (2020) · American Journal of Neuroradiology · doi:10.3174/ajnr.a6799 · Cited by 62

Current treatment in COVID-19 disease: a rapid review

Guerra, M. A. R., Jadhav, P., & Vittorio, T. J. (2021) · Drugs in Context · doi:10.7573/dic.2020-10-3 · Cited by 62

Microglial Implications in SARS-CoV-2 Infection and COVID-19: Lessons From Viral RNA Neurotropism and Possible Relevance to Parkinson’s Disease

Awogbindin, I. O., Ben‐Azu, B., Olusola, B. A., Akinluyi, E. T., Adeniyi, P. A., Paolo, T. D., & Tremblay, M. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.670298 · Cited by 61

Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management

Matucci‐Cerinic, M., Bruni, C., Allanore, Y., Clementi, M., Dagna, L., Damjanov, N. S., de Paulis, A., Denton, C. P., Distler, O., Fox, D. A., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217407 · Cited by 61

Heparin‐induced thrombocytopenia with thrombosis in COVID‐19 adult respiratory distress syndrome

Riker, R. R., May, T., Fraser, G. L., Gagnon, D. J., Bandara, M., Zemrak, W. R., & Seder, D. B. (2020) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12390 · Cited by 61

ANTIPHOSPHOLIPID-LIKE SYNDROME INDUCED BY COVID19: A CASE REPORT STUDY

Marinkovic, S. P., Anastasovski, A., & Todorovska, L. (2024) · Journal of Morphological Sciences · doi:10.55302/jms2471171pm

The changes of Coagulation State in Patients Contracted with SARS-COV-19

Nosrati, A. (2020) · Iranian journal of pathology · doi:10.30699/ijp.2020.129354.2427 · Cited by 1

Antiphospholipid Antibodies in Critically Ill Patients With COVID‐19

Xiao, M., Zhang, Y., Zhang, S., Qin, X., Xia, P., Cao, W., Jiang, W., Chen, H., Ding, X., Zhao, H., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41425 · Cited by 174

Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients

Zhang, Y., Cao, W., Jiang, W., Xiao, M., Li, Y., Tang, N., Liu, Z., Yan, X., Zhao, Y., Li, T., et al. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02182-9 · Cited by 162

Evaluation of Antiphospholipid Antibodies in COVID-19 Patients with Coagulopathy.

Nosrati, A., Torabizadeh, Z., Kheirkhah, D., Larijani, L. V., Alizade-Navaei, R., Mobini, M., Aliyali, M., Abedi, S., & Mehravaran, H. (2022) · PubMed Central · Cited by 2